Literature DB >> 8230601

Genetic factors in multiple sclerosis.

J R Oksenberg1, A B Begovich, H A Erlich, L Steinman.   

Abstract

OBJECTIVE: To evaluate the role of candidate genes in the susceptibility to multiple sclerosis (MS) and describe the role of T-cell receptor (TCR) gene rearrangements in the MS brain lesion in identifying a major target of the immune response in this disease. DATA SOURCES: MEDLINE, bibliography review of published data, and unpublished studies. STUDY SELECTION: Published studies using novel molecular approaches to analyze the role of the major histocompatibility complex (MHC) and TCR gene complexes, as well as other candidate genes, in susceptibility to MS. We analyze epigenetic events involving TCR genes in individuals with MS and describe recent clinical trials in which immunotherapy has been attempted. DATA SYNTHESIS: Consistent with a polygenic model for disease predisposition, MHC and TCR gene associations with MS are relatively weak. Despite intensive research, no other putative "MS genes" have been firmly established. The analysis of TCR rearrangements in the brain lesion has helped to identify a major target of the immune response in MS.
CONCLUSION: Understanding the genetic basis for autoimmune demyelination will offer new possibilities for the treatment of this illness.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230601

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  14 in total

Review 1.  Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice.

Authors:  David Luckey; Dikshya Bastakoty; Ashutosh K Mangalam
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

2.  The role of human leucocyte antigen genes in the development of malignant disease.

Authors:  W M Howell; D B Jones
Journal:  Clin Mol Pathol       Date:  1995-12

3.  Alterations in the activity of phospholipases A2 in postmortem white matter from patients with multiple sclerosis.

Authors:  S J Huterer; W W Tourtellotte; J R Wherrett
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

Review 4.  Cell replacement therapies to promote remyelination in a viral model of demyelination.

Authors:  Emanuele Tirotta; Kevin S Carbajal; Chris S Schaumburg; Lucia Whitman; Thomas E Lane
Journal:  J Neuroimmunol       Date:  2010-06-02       Impact factor: 3.478

Review 5.  Promoting remyelination through cell transplantation therapies in a model of viral-induced neurodegenerative disease.

Authors:  Vrushali Mangale; Laura L McIntyre; Craig M Walsh; Jeanne F Loring; Thomas E Lane
Journal:  Dev Dyn       Date:  2018-09-06       Impact factor: 3.780

6.  Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis.

Authors:  Joel N H Stern; Zsolt Illés; Jayagopala Reddy; Derin B Keskin; Masha Fridkis-Hareli; Vijay K Kuchroo; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

7.  Absence of IFN-γ increases brain pathology in experimental autoimmune encephalomyelitis-susceptible DRB1*0301.DQ8 HLA transgenic mice through secretion of proinflammatory cytokine IL-17 and induction of pathogenic monocytes/microglia into the central nervous system.

Authors:  Ashutosh K Mangalam; Ningling Luo; David Luckey; Louisa Papke; Alyssa Hubbard; Arika Wussow; Michele Smart; Shailendra Giri; Moses Rodriguez; Chella David
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

8.  HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis.

Authors:  D S Bradley; G H Nabozny; S Cheng; P Zhou; M M Griffiths; H S Luthra; C S David
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

9.  HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma.

Authors:  Ashutosh Mangalam; David Luckey; Eati Basal; Marshall Behrens; Moses Rodriguez; Chella David
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

10.  HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice.

Authors:  Ashutosh Mangalam; David Luckey; Eati Basal; Megan Jackson; Michele Smart; Moses Rodriguez; Chella David
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.